Phase2 study on the validity of initiating treatment during midtrimester for GDM patients
Phase 2
- Conditions
- GDM
- Registration Number
- JPRN-UMIN000030231
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
overt DM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method large for gestational age(%)
- Secondary Outcome Measures
Name Time Method Incidence of macrosomia SGA shoulder dystocia GDM associated neonatal complications